Abramson fellow receives award from Society for Pediatric Research

May 05, 2003

(Philadelphia, PA) - Christina M. Coughlin, MD, PhD, a research fellow in the University of Pennsylvania's Abramson Family Cancer Research Institute, has received the Fellow Basic Research Award for 2003 from the Society for Pediatric Research. The prize was awarded for her work in showing that modified immune cells can efficiently deliver genetic material to stimulate a desirable immune response. This research could lead the way for future cancer vaccines for children.

Dr. Coughlin conducts research in the laboratory of Robert H. Vonderheide, MD, DPhil at Penn's Abramson Family Cancer Research Institute; she is also a pediatric hematology-oncology fellow at The Children's Hospital of Philadelphia (CHOP).

Her research, conducted in collaboration with Dr. Vonderheide and Stephan A. Grupp, M.D., Ph.D., director of Stem Cell Biology at CHOP, included the manipulation of immune cells known as CD40-activated B cells to carry RNA produced by tumors and viruses. The activated B cells could stimulate the creation of other immune cells capable of recognizing - and killing - the tumors and viruses that also carry these RNA strains.

"We are particularly proud of this work and the collaborative initiative among all the investigators at both institutions," said Dr. Vonderheide. "This award recognizes Dr. Coughlin's leadership at the national level and the beneficiaries of this work are children with cancer."

Dr. Coughlin will be presented with her award at the Society for Pediatric Research Annual Meeting in Seattle, Washington, May 3-6. In addition, she will present her work at a platform session during the meeting.

The Society for Pediatric Research encourages young investigators to engage in research that is of benefit to children by providing a forum for interchange of ideas and an opportunity for young investigators to present their work.

The Society for Pediatric Research annually honors students, house officers and fellows engaged in pediatric research. The awards are designed to encourage pediatricians in training to pursue careers in academic pediatrics. Winning candidates are selected by a committee from the Society for Pediatric Research based on the quality of the work presented in the abstract.

The Abramson Cancer Center of the University of Pennsylvania is one of only 31 cancer centers in the nation designated by the National Cancer Institute (NCI) as a Comprehensive Cancer Center. This status reflects the Cancer Center's excellence in research, treatment, community outreach, professional education, and information services. The NCI mark of excellence assures patients and families that they have selected physicians and services that are recognized nationally and that they will benefit from the latest research advances.
-end-


University of Pennsylvania School of Medicine

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.